August 9, 2016 / 8:37 PM / a year ago

BRIEF-Cardiome Pharma says announces XYDALBA single dose infusion approval by european medicines agency

1 Min Read

Aug 9 (Reuters) - Cardiome Pharma Corp

* Cardiome announces XYDALBA single dose infusion approval by european medicines agency

* Anticipate XYDALB will be available to physicians within some of major territories under license by cardiome during q4 of 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below